Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two Icodextrin Exchanges in Children on Chronic Peritoneal Dialysis
NCT07168343Not yet recruiting
- Sponsor
- National University Health System
- Start
- Feb 2026
- Primary completion
- Jun 2028
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Randomised, open-label trial of icodextrin in Fluid overload and hypertension (HTN) (2 arms), sponsored by National University Health System. Primary endpoint: Mean change in 24-hour ultrafiltration volume at 8 weeks. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
icodextrin
03
Conditions
Fluid overloadhypertension (HTN)
Beyond the preview
Go deeper on NCT07168343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07168343.